Results 231 to 240 of about 112,955 (338)

5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts

open access: gold, 2014
Han‐Ching Lin   +9 more
openalex   +2 more sources

Applications of Chitosan, an Eco‐Friendly Biopolymer in Agricultural Systems, Herbal Products, and Functional Foods: A Review

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Chitosan is highlighted for its industrial applications include food processing and preservation, pharmaceuticals, agriculture systems, and environmental protection. ABSTRACT Chitin, the natural biopolymer of the world next to cellulose, is a modified biodegradable polysaccharide.
Saeedeh Karimlar   +4 more
wiley   +1 more source

Antioxidant, Hypotensive, and Antidiabetic Breakthroughs: Bromelain Hydrolysis Unlocks Quinoa's Peptide Potential - <i>In Silico</i> and <i>In Vitro</i> Approach. [PDF]

open access: yesJ Agric Food Chem
Manzanilla-Valdez ML   +5 more
europepmc   +1 more source

Lipoxygenase

open access: yesJournal of Japan Oil Chemists' Society, 1965
openaire   +2 more sources

Lipoxygenases

open access: yes, 1982
Vliegenthart, J.F.G., Veldink, G.A.
openaire   +2 more sources

Oroxylum indicum (L.) Bark Ameliorates Anxiety and Depression: Evidence From Experimental and Computational Studies

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
The study evaluated the antioxidant and neuropharmacological effects of Oroxylum indicum bark (MOIB), identifying 20 phytochemicals through GC–MS analysis. MOIB exhibited anxiolytic, sedative, and antidepressant effects in various behavioral tests, with two compounds (CID 550198 and CID 10393) showing strong binding affinities to targeted receptors and
Md. Aktaruzzaman   +12 more
wiley   +1 more source

Anti‐Neuroinflammation Activity of Essential Oils and Fatty Acids

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Neuroinflammation plays a pivotal role in the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD). Current pharmacological interventions, such as NSAIDs and corticosteroids, are limited by systemic toxicity and insufficient efficacy in targeting chronic neuroinflammatory processes.
Zelong Jin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy